Marshall Wace
VECT

Marshall Wace’s VectivBio Holding AG Ordinary Shares VECT Stock Holding History

Marshall Wace’s Portfolio VECT Stock Details VECT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,669,656
Closed -$14.4M – 3157
2023
Q1 		$14.4M Buy
1,669,656
+300,000
+22% +$2.47M 0.03% 583
2022
Q4 		$11.8M Buy
1,369,656
+867,000
+172% +$6.98M 0.03% 720
2022
Q3 		$3.02M Hold
502,656
– – 0.01% 1743
2022
Q2 		$2.71M Buy
+502,656
New +$2.71M 0.01% 1786

Other funds holding VECT

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
VI
Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Marshall Wace's VECT Position: Q2 2023 in Review

Marshall Wace sold out of VectivBio Holding AG Ordinary Shares (VECT) in Q2 2023, closing a stake of 1,669,656 shares — an estimated $14.4M sold.

Marshall Wace first reported a position in VECT in Q2 2022 and held it in 4 quarters. The position peaked at $14.4M in Q1 2023. 49 funds tracked by Wall St. Rank hold VECT as of Q2 2023.

  • Marshall Wace reported no remaining VectivBio Holding AG Ordinary Shares position as of Q2 2023 after selling out during the quarter.
  • Marshall Wace sold 1,669,656 VectivBio Holding AG Ordinary Shares shares in Q2 2023, an estimated $14.4M.
  • Marshall Wace first reported a position in VectivBio Holding AG Ordinary Shares in Q2 2022 and held it in 4 quarters.
  • Marshall Wace's VectivBio Holding AG Ordinary Shares position peaked at $14.4M in Q1 2023.
  • 49 funds tracked by Wall St. Rank held VectivBio Holding AG Ordinary Shares as of Q2 2023.

Based on Marshall Wace's 13F filing for Q2 2023, filed 14 Aug 2023.